Over the years, IKA has become an invaluable resource for eye care professionals.
From revised patient flow to smarter tech adoption, ophthalmologists share which changes from 2020 have become cornerstones of modern care—and how they’re preparing for the next big disruption
Evidence-based medicine can lead to personalized care, better results for patients
At ARVO 2025, in Salt Lake City, Utah, Alex Choi discussed his poster on APOE carrier genetic status and its relation to Alzheimer disease as well as changes of the retina that might reflect early signs leading to an earlier diagnosis of the disease
A novel use of minor salivary glands offers lasting relief and visual improvement.
Technical details, communication style key to presbyopia-correcting IOL journey.
Optimizing corneal neurotization outcomes with cryopreserved amniotic membrane.
Research can drive opportunities for patients with rare diseases
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
These tools help fill a gap that current technologies cannot achieve as effectively.
Epi-on corneal crosslinking is advancing through innovations like supplemental oxygen, chemical oxygenation, and laser-assisted techniques.
Grazia Pertile, MD, discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.
At ARVO 2025, in Salt Lake City, Utah, Patipol Tiyajamorn, talked about his poster on using graph neural networks to identify fast glaucoma progressors solely using optic nerve head morphology at a single time point
Ophthalmologist offers pearls for use of technology in daily work.
At ARVO 2025, in Salt Lake City, Utah, Danielle Gauthier talked about her poster on autosomal dominant Alzheimer disease in relation to optic nerve head drusen.
A discussion with Shigeru Kinoshita, MD, PhD; and Edward J. Holland, MD.
Retinal specialists conclude their discussion with key highlights from each patient case of retinal vascular disease and pearls the audience can apply in their practice.
Randomly assigned controlled trials key in increasing understanding of disease.
Ophthalmologists discuss the most impactful advancements reshaping patient care over five decades.
At the Envision Summit 2025 in San Juan, Puerto Rico, Sara Wester, MD, discussed the Women Leaders in Eye Health session at the conference and the donation from Orbis that supported the session.
Direct selective laser trabeculoplasty enhances the experience for both patients and physicians, he notes, while also mitigating issues related to poor adherence and ocular surface disease from topical therapy.
In this Q&A, Luke Lindsell, OD, MD, shares his insights on emerging therapies in retina, the evolving role of optometrists in retinal disease management, and the importance of comanagement in patient care.
Wendy Lee, MD, MS, shares how she integrates aesthetic and functional care in oculoplastics.
Paul Badawi, co-founder and CEO of Sight Sciences, sits down with host Neda Shamie, MD, to discuss his journey into the field of eye care, what motivates him, the transformative approach to glaucoma patient care, and the spark that led him and his ophthalmologist brother, David Badawi, MD, to start the company together.
President Joel S. Schuman, MD, highlights the group’s mission and vision for the future—uniting 17 working groups and over 80 stakeholders.
The new standard: Stabilizing keratoconus and improving vision.
At ARVO 2025, in Salt Lake City, Utah, Yuhua Zhang, PhD, talked about his presentation on in vivo imaging of retinal pigment epithelium metabolic function in age-related macular degeneration
Use of the LENSAR Ally femtosecond laser for arcuate incisions was associated with improved early visual outcomes and reduced need for postoperative adjustments in premium IOL patients.
Ophthalmologists discuss the most impactful advancements reshaping patient care over five decades.